Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A

NASDAQ:MRVI   3:59:54 PM EDT
26.59
-0.19 (-0.71%)
Other Pre-Announcement

Maravai Lifesciences Reports Q2 Financial Results

Published: 08/04/2022 21:04 GMT
Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A (MRVI) - Maravai Lifesciences Reports Second Quarter 2022 Financial Results.
Maravai Lifesciences Holdings Inc - Quarterly Revenue of $242.7 Million, an Increase of 11%.
Maravai Lifesciences Holdings Inc - Total Revenue for 2022 is Projected to Be in Range of $880.0 Million to $910.0 Million.
Maravai Lifesciences Holdings Inc - Adjusted Fully Diluted EPS (non-GAAP) is Now Expected to Be in Range of $1.70 - $1.80 per Share.